Stocks
Novo Nordisk (NVO) Revenue US GAAP (year values) |
|||||||||
| 2021 | 2021 | 2022 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| Revenue | ? | 140 800 000 000 | 140 800 000 000 | 176 954 000 000 | 176 954 000 000 | 232 261 000 000 | 258 003 000 000 | ||
| Changes by years, y/y, % | +11% | 0% | +26% | 0% | +31% | +15.7% | |||
Novo Nordisk. Revenue US GAAP
Novo Nordisk. Revenue US GAAP, changes, %
Novo Nordisk. Revenue US GAAP, sum by quarters
Novo Nordisk (NVO) Revenue US GAAP (quarter values) |
||||||||
| 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | LTM ? | |||
| Revenue | ? | 54 300 000 000 | 58 731 000 000 | 65 863 000 000 | 65 349 000 000 | 68 060 000 000 | 258 003 000 000 | |
| Changes by years, y/y, % | +32% | +29% | +37% | +22% | +25% | |||
| Changes by quarters, q/q, % | +8% | +12% | -1% | +4% | ||||
